Advanced Biological Laboratories has been granted additional patents in Hong Kong (HK1121187) to further protect its intellectual property and reinforce the already existing core patent entitled ”
Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof” (US Patent 8,367,317, Publication nº US8367317 B2).